115 related articles for article (PubMed ID: 8396402)
21. Spliced human endogenous retroviral HERV-H env transcripts in T-cell leukaemia cell lines and normal leukocytes: alternative splicing pattern of HERV-H transcripts.
Lindeskog M; Blomberg J
J Gen Virol; 1997 Oct; 78 ( Pt 10)():2575-85. PubMed ID: 9349478
[TBL] [Abstract][Full Text] [Related]
22. Reactivity of monoclonal antibodies established against a recombinant human endogenous retrovirus-K (HERV-K) envelope protein.
Vogetseder W; Feng J; Dierich MP
Immunol Lett; 1995 May; 46(1-2):129-34. PubMed ID: 7590908
[TBL] [Abstract][Full Text] [Related]
23. Frequent detection of HIV- and IgG-specific IgM and IgA antibodies in HIV-positive cord-blood sera: fine analysis by western blot.
Schüpbach J; Wunderli W; Kind C; Kernen R; Baumgartner A; Tomasik Z
AIDS; 1989 Sep; 3(9):583-9. PubMed ID: 2506903
[TBL] [Abstract][Full Text] [Related]
24. Detection of antibodies to a recombinant gag protein derived from human endogenous retrovirus clone 4-1 in autoimmune diseases.
Hishikawa T; Ogasawara H; Kaneko H; Shirasawa T; Matsuura Y; Sekigawa I; Takasaki Y; Hashimoto H; Hirose S; Handa S; Nagasawa R; Maruyama N
Viral Immunol; 1997; 10(3):137-47. PubMed ID: 9344336
[TBL] [Abstract][Full Text] [Related]
25. Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides.
Filice G; Soldini L; Orsolini P; Razzini E; Gulminetti R; Campisi D; Chiapparoli L; Cattaneo E; Achilli G
Microbiologica; 1991 Jul; 14(3):185-94. PubMed ID: 1717811
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the antibody response specific for the human endogenous retrovirus HTDV/HERV-K.
Boller K; Janssen O; Schuldes H; Tönjes RR; Kurth R
J Virol; 1997 Jun; 71(6):4581-8. PubMed ID: 9151852
[TBL] [Abstract][Full Text] [Related]
27. [HIV antigen study].
Reissigl H; Rosmanith P; Schönitzer D
Beitr Infusionsther; 1989; 24():14-7. PubMed ID: 2481531
[TBL] [Abstract][Full Text] [Related]
28. IDDM patients neither show humoral reactivities against endogenous retroviral envelope protein nor do they differ in retroviral mRNA expression from healthy relatives or normal individuals.
Badenhoop K; Donner H; Neumann J; Herwig J; Kurth R; Usadel KH; Tönjes RR
Diabetes; 1999 Jan; 48(1):215-8. PubMed ID: 9892247
[TBL] [Abstract][Full Text] [Related]
29. Immunogenicity testing of a novel engineered HIV-1 envelope gp140 DNA vaccine construct.
Kumar S; Yan J; Muthumani K; Ramanathan MP; Yoon H; Pavlakis GN; Felber BK; Sidhu M; Boyer JD; Weiner DB
DNA Cell Biol; 2006 Jul; 25(7):383-92. PubMed ID: 16848679
[TBL] [Abstract][Full Text] [Related]
30. A natural antisense RNA derived from the HIV-1 env gene encodes a protein which is recognized by circulating antibodies of HIV+ individuals.
Vanhée-Brossollet C; Thoreau H; Serpente N; D'Auriol L; Lévy JP; Vaquero C
Virology; 1995 Jan; 206(1):196-202. PubMed ID: 7831774
[TBL] [Abstract][Full Text] [Related]
31. Serological response to human endogenous retrovirus K in melanoma patients correlates with survival probability.
Hahn S; Ugurel S; Hanschmann KM; Strobel H; Tondera C; Schadendorf D; Löwer J; Löwer R
AIDS Res Hum Retroviruses; 2008 May; 24(5):717-23. PubMed ID: 18462078
[TBL] [Abstract][Full Text] [Related]
32. Human endogenous retrovirus W family envelope gene activates the small conductance Ca2+-activated K+ channel in human neuroblastoma cells through CREB.
Li S; Liu ZC; Yin SJ; Chen YT; Yu HL; Zeng J; Zhang Q; Zhu F
Neuroscience; 2013 Sep; 247():164-74. PubMed ID: 23727510
[TBL] [Abstract][Full Text] [Related]
33. Env gene expression of human endogenous retrovirus-k and human endogenous retrovirus-w in childhood acute leukemia cells.
Januszkiewicz-Lewandowska D; Nowicka K; Rembowska J; Fichna M; Żurawek M; Derwich K; Nowak J
Acta Haematol; 2013; 129(4):232-7. PubMed ID: 23328642
[TBL] [Abstract][Full Text] [Related]
34. Chromosomal distribution and coding capacity of the human endogenous retrovirus HERV-W family.
Voisset C; Bouton O; Bedin F; Duret L; Mandrand B; Mallet F; Paranhos-Baccala G
AIDS Res Hum Retroviruses; 2000 May; 16(8):731-40. PubMed ID: 10826480
[TBL] [Abstract][Full Text] [Related]
35. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
36. Blood donations and viruses.
Schennach H; Schönitzer D; Wachter H; Fuchs D
Lancet; 1997 May; 349(9061):1327-8. PubMed ID: 9142092
[No Abstract] [Full Text] [Related]
37. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
[TBL] [Abstract][Full Text] [Related]
38. Chromosomal assignment of human endogenous retrovirus K (HERV-K) env open reading frames.
Mayer J; Meese E; Mueller-Lantzsch N
Cytogenet Cell Genet; 1997; 79(1-2):157-61. PubMed ID: 9533039
[TBL] [Abstract][Full Text] [Related]
39. Absence of recoverable infectious virus and unique immune responses in an asymptomatic HIV+ long-term survivor.
Schwartz D; Sharma U; Busch M; Weinhold K; Matthews T; Lieberman J; Birx D; Farzedagen H; Margolick J; Quinn T
AIDS Res Hum Retroviruses; 1994 Dec; 10(12):1703-11. PubMed ID: 7888230
[TBL] [Abstract][Full Text] [Related]
40. Molecular cloning, expression, and biological characterization of an HTLV-II envelope glycoprotein: HIV-1 expression is permissive for HTLV-II-induced cell fusion.
Wang B; Agadjanyan MG; Srikantan V; Ugen KE; Hall W; Kaplan MH; Dang K; Williams WV; Weiner DB
AIDS Res Hum Retroviruses; 1993 Sep; 9(9):849-60. PubMed ID: 8257634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
